These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 31404304

  • 1. Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.
    Massimino M, Stella S, Tirrò E, Consoli ML, Pennisi MS, Puma A, Vitale SR, Romano C, Zammit V, Stagno F, Di Raimondo F, Manzella L.
    Oncol Lett; 2019 Sep; 18(3):2648-2653. PubMed ID: 31404304
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report.
    Massimino M, Stella S, Tirrò E, Consoli ML, Pennisi MS, Puma A, Vitale SR, Romano C, Zammit V, Stagno F, DI Raimondo F, Manzella L.
    Anticancer Res; 2019 Jul; 39(7):3949-3954. PubMed ID: 31262926
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Molecular Remission after Treatment with Imatinib in a Chronic Myeloid Leukemia Patient with Extreme Thrombocytosis Harboring Rare e14a3 (b3a3) BCR::ABL1 Transcript: A Case Report.
    Zhang X, Sun H, Su Y, Yi H.
    Curr Oncol; 2022 Oct 28; 29(11):8171-8179. PubMed ID: 36354705
    [Abstract] [Full Text] [Related]

  • 4. Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report.
    Manzella L, Tirrò E, Vitale SR, Puma A, Consoli ML, Tambè L, Pennisi MS, DI Gregorio S, Romano C, Tomarchio C, DI Raimondo F, Stagno F.
    In Vivo; 2020 Oct 28; 34(3):1481-1486. PubMed ID: 32354950
    [Abstract] [Full Text] [Related]

  • 5. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X, Pan J, Qiu H, Cen J, Xue Y, Chen S, Shen H, Yao L, Zhang J, Wu Y, Chen Y.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar 28; 35(3):210-4. PubMed ID: 24666486
    [Abstract] [Full Text] [Related]

  • 6. Breakpoint mapping of a t(9;22;12) chronic myeloid leukaemia patient with e14a3 BCR-ABL1 transcript using Nanopore sequencing.
    Zhao H, Chen Y, Shen C, Li L, Li Q, Tan K, Huang H, Hu G.
    J Gene Med; 2021 Jan 28; 23(1):e3276. PubMed ID: 32949441
    [Abstract] [Full Text] [Related]

  • 7. Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report.
    Ramdohr F, Fabarius A, Maier B, Bretschneider D, Jauch A, Monecke A, Metzeler KH, Janssen JWG, Schlenk RF, Kayser S.
    Front Oncol; 2022 Jan 28; 12():960914. PubMed ID: 36106102
    [Abstract] [Full Text] [Related]

  • 8. Detection and Clinical Implications of a Novel BCR-ABL1 E12A2 Insertion/Deletion in a CML Patient Expressing the E13A2 Isoform.
    Stella S, Massimino M, Tirrò E, Vitale SR, Accurso V, Puma A, Pennisi MS, DI Gregorio S, Romano C, DI Raimondo F, Siragusa S, Manzella L.
    Anticancer Res; 2019 Dec 28; 39(12):6965-6971. PubMed ID: 31810968
    [Abstract] [Full Text] [Related]

  • 9. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
    Kurita D, Hatta Y, Hojo A, Kura Y, Sawada U, Kanda Y, Takei M.
    Cancer Genet; 2016 Apr 28; 209(4):161-5. PubMed ID: 26854094
    [Abstract] [Full Text] [Related]

  • 10. Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients.
    Arun AK, Senthamizhselvi A, Mani S, Vinodhini K, Janet NB, Lakshmi KM, Abraham A, George B, Srivastava A, Srivastava VM, Mathews V, Balasubramanian P.
    Int J Lab Hematol; 2017 Jun 28; 39(3):235-242. PubMed ID: 28035733
    [Abstract] [Full Text] [Related]

  • 11. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M, Ottone T, Alfonso V, Ferrari A, Conte E, Divona M, Bianchi MP, Ricciardi MR, Mirabilii S, Licchetta R, Campagna A, Cicconi L, Galassi G, Pelliccia S, Leporace A, Lo Coco F, Tafuri A.
    BMC Cancer; 2019 Jan 10; 19(1):50. PubMed ID: 30630459
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre.
    Qin YZ, Jiang Q, Jiang H, Lai YY, Shi HX, Chen WM, Yu L, Huang XJ.
    Br J Haematol; 2018 Sep 10; 182(5):693-700. PubMed ID: 29974949
    [Abstract] [Full Text] [Related]

  • 13. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
    Duan MH, Li H, Cai H.
    Leuk Res; 2017 Aug 10; 59():8-11. PubMed ID: 28527402
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib.
    Genthon A, Nicolini FE, Huguet F, Colin-Gil C, Berger M, Saugues S, Janel A, Hayette S, Cohny-Makhoul P, Cadoux N, Cayuela JM, Campos L, Guyotat D, Flandrin-Gresta P.
    Oncotarget; 2020 Jun 30; 11(26):2560-2570. PubMed ID: 32655840
    [Abstract] [Full Text] [Related]

  • 16. Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts.
    Xue M, Wang Q, Huo L, Wen L, Yang X, Wu Q, Pan J, Cen J, Ruan C, Wu D, Chen S.
    Leuk Lymphoma; 2019 Dec 30; 60(12):3051-3057. PubMed ID: 31258010
    [Abstract] [Full Text] [Related]

  • 17. How to detect the rare BCR-ABL (e14a3) transcript: A case report and literature review.
    Hu LH, Pu LF, Yang DD, Zhang C, Wang HP, Ding YY, Li MM, Zhai ZM, Xiong S.
    Oncol Lett; 2017 Nov 30; 14(5):5619-5623. PubMed ID: 29113191
    [Abstract] [Full Text] [Related]

  • 18. [Molecular analysis of the BCR-ABL1 fusion gene in a chronic myeloid leukemia patient with BCR-ABL1 International Scale-undetectable disease].
    Kawamata N, Watanabe R.
    Rinsho Ketsueki; 2019 Nov 30; 60(7):767-772. PubMed ID: 31391364
    [Abstract] [Full Text] [Related]

  • 19. Novel Four-Way Variant Translocation, t(1;9;22;16)(q21;q34;q11.2;q24), in a Patient with Chronic Myeloid Leukemia.
    Son HJ, Lee JH.
    Diagnostics (Basel); 2024 Jan 30; 14(3):. PubMed ID: 38337818
    [Abstract] [Full Text] [Related]

  • 20. A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.
    Lyu X, Yang J, Wang X, Hu J, Liu B, Zhao Y, Guo Z, Liu B, Fan R, Song Y.
    Mol Cytogenet; 2016 Jan 30; 9():47. PubMed ID: 27350795
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.